References
- ShanderAFinancial and clinical outcomes associated with surgical bleeding complicationsSurgery20071424 SupplS20S2518019945
- MariettaMFacchiniLPedrazziPBusaniSTorelliGPathophysiology of bleeding in surgeryTransplant Proc200638381281416647479
- StokesMEYeXShahMImpact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patientsBMC Health Serv Res20111113521627788
- WrightJDAnanthCVLewinSNPatterns of use of hemostatic agents in patients undergoing major surgeryJ Surg Res2014186145846623993203
- GabayMBoucherBAAn essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasisPharmacotherapy201333993595523686938
- SundaramCPKeenanACEvolution of hemostatic agents in surgical practiceIndian J Urol201026337437821116358
- FaganNLChauJMaleskerMATopical hemostatsUS Pharmacist20103511HS2HS8 Available from: http://www.uspharmacist.com/content/d/feature/c/23860/Accessed May 5, 2014
- AlbalaDMRiebmanJBKocharianRHemostatis during urologic surgery: fibrin sealant compared with absorbable hemostatRev Urol201517253026028998
- FischerCPBochicchioGShenJPatelBBatillerJHartJCA prospective, randomized, controlled trial of the efficacy and safety of fibrin pad as an adjunct to control soft tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic surgeryJ Am Coll Surg201321738539323969113
- NativOPatelBShenJBatillerJHornSHartJCSafety and hemostatic efficacy of fibrin pad in partial nephrectomy: results of an open-label phase I and a randomized, standard-of-care-controlled phase I/II studyBMC Nephrol20121314723137020
- NassoGPianconeFBonifaziRProspective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgeryAnn Thorac Surg2009881520152619853105
- SirlakMEryilmazSYaziciogluLComparative study of micro-fibrillar collagen hemostat (Colgel) and oxidized cellulose (Surgicel) in high transfusion-risk cardiac surgeryJ Thorac Cardiovasc Surg200312666667014502137
- KrishnanSConnorTMLeslieRStemkowskiSShanderAChoice of hemostatic agent and hospital length of stay in cardiovascular surgerySemin Cardiothorac Vasc Anesth20091322523019951982
- Premier, Inc. [webpage on the Internet]Mission and visionCharlotte, NCPremier, Inc2014 Available from: https://www.premierinc.com/wps/portal/premierinc/public/aboutpremier/missionvisionAccessed May 5, 2014
- RosenbaumPRRubinDBThe central role of the propensity score in observational studies for causal effectsBiometrika19837014155
- AustinPCA critical appraisal of propensity-score matching in the medical literature between 1996 and 2003Stat Med200827122037204918038446
- SeegerJDWilliamsPLWalkerAMAn application of propensity score matching using claims dataPharmacoepidemiol Drug Saf200514746547615651087
- SteinerPMCookDPropensity matching and propensity scoresLittleTDThe Oxford Handbook of Quantitative Methods in Psychology1New YorkOxford University Press2013
- CarlessPAHenryDAAnthonyDMFibrin sealant use for minimising peri-operative allogeneic blood transfusion [review]Cochrane Database Syst Rev20032CD00417112804501
- MartynDKocharianRLimSReduction in hospital costs and resource consumption associated with the use of advanced topical hemostats during inpatient proceduresJ Med Econ20151861825271379